Generics - Boardroom

Filter

Current filters:

Boardroom

Popular Filters

226 to 250 of 1322 results

India’s Zydus Cadila posts 94% rise in 2nd-qtr net profit

31-10-2013

For the second fiscal quarter ended September 30, 2013, Indian drugmaker Zydus Cadila’s net profit…

FinancialGenericsZydus Cadila

Marc Dunoyer appointed chief financial officer of AstraZeneca

Marc Dunoyer appointed chief financial officer of AstraZeneca

31-10-2013

AstraZeneca today announced that Marc Dunoyer has been appointed chief financial officer and will join…

AstraZenecaBoardroomEuropePharmaceutical

AstraZeneca’s patent protection for Pulmicort Respules upheld by US court

AstraZeneca’s patent protection for Pulmicort Respules upheld by US court

31-10-2013

The US Court of Appeals for the Federal Circuit has reversed and remanded for further proceedings a trial…

AstraZenecaGenericsLegalNorth AmericaPulmicort Respules

Brazilian pharmachemical sector discussed at parliamentary public hearing

31-10-2013

Fiocruz's Production and Innovation in Health vice-president Jorge Bermudez highlighted the importance…

FinancialGenericsProductionSouth America

Teva Pharmaceutical says CEO Jeremy Levin has resigned

Teva Pharmaceutical says CEO Jeremy Levin has resigned

30-10-2013

Israel-based Teva Pharmaceutical Industries, say that, despite its recent denials of a rift with its…

BoardroomGenericsManagementTeva Pharmaceutical Industries

Gerhard Schmitz to join Merck KGaA as new head of global accounting

Gerhard Schmitz to join Merck KGaA as new head of global accounting

30-10-2013

Merck KGaA announced today that Gerhard Schmitz will join the pharmaceutical, chemical and life science…

BoardroomEuropeMerck KGaAPharmaceutical

“Generics, Get the Facts Straight” - subject of South Africa workshop

“Generics, Get the Facts Straight” - subject of South Africa workshop

29-10-2013

South Africa’s National Association of Pharmaceutical Manufacturers (NAPM) held a workshop for health…

GenericsPricingRegulationRest of the WorldSouth Africa

Bumper 3rd-qtr for Actavis, with 57% net revenue leap

Bumper 3rd-qtr for Actavis, with 57% net revenue leap

29-10-2013

US generics major Actavis has reported a net revenue increase of 57% to $2.01 billion for the third quarter…

ActavisFinancialGenerics

Japan’s MoF seen as another opponent to premium system

Japan’s MoF seen as another opponent to premium system

29-10-2013

The Budget Bureau of Japan’s Ministry of Finance, in a meeting of the Fiscal System Council last week,…

Asia-PacificGenericsPharmaceuticalPricing

European generic drugmakers call for maintenance of current robust WHO INN system

24-10-2013

The World Health Organization Consultation on International Non-proprietary Names (INN), open session…

BiosimilarsEuropeGenericsRegulation

EXPERT VIEW: Talent acquisition at the heart of M&A

EXPERT VIEW: Talent acquisition at the heart of M&A

22-10-2013

Mergers and acquisitions are common – 111 M&As took place in the UK in the second quarter of 2013 alone…

BoardroomInterviewsMergers & AcquisitionsPharmaceutical

Rise or demise of Japan’s generics by P Reed Maurer

Rise or demise of Japan’s generics by P Reed Maurer

16-10-2013

Generics in Japan are a work in progress. Presently they account for about 28% of pharmaceutical volume,…

Asia-PacificGenericsMarkets & MarketingPricing

Dramatic increase in use of generic drugs in Japan confirmed

Dramatic increase in use of generic drugs in Japan confirmed

15-10-2013

A subcommittee of Japan’s Central Social Insurance Medical Council looked at the effect of the April…

Asia-PacificGenericsMarkets & MarketingRegulation

US FDA approves Teva’s generic TOBI

US FDA approves Teva’s generic TOBI

14-10-2013

Teva Pharmaceutical Industries says that the US Food and Drug Administration has granted approval of…

Antibiotics and Infectious diseasesGenericsNovartisRare diseasesRegulationTeva Pharmaceutical IndustriesTobi

EGA views future for generics and biosimilars in Europe

EGA views future for generics and biosimilars in Europe

14-10-2013

The European Generic medicines Association (EGA) recently launched its industrial policy vision for the…

BiosimilarsEuropeGenericsMarkets & MarketingRegulation

Akorn buy of Hi-Tech Pharmacal delayed by FTC request

13-10-2013

In a filing with the US Stock Exchange Commission, USA-based niche generics firm Akorn announced that…

AkornGenericsHi-Tech PharmacalMergers & Acquisitions

Acura Pharma settles with Par and Impax over Oxecta

Acura Pharma settles with Par and Impax over Oxecta

11-10-2013

US specialty pharma firm Acura Pharmaceuticals saw its shares leap as much as 28% after it said that…

Acura PharmaceuticalsGenericsImpax LaboratoriesLicensingNeurologicalNorth AmericaOxectaPar PharmaceuticalPatents

Increase in chronic and lifestyle-associated diseases to Brazil market sales

Increase in chronic and lifestyle-associated diseases to Brazil market sales

11-10-2013

Brazil has emerged as a manufacturing hub for pharmaceutical and biotechnology companies, with the pharma…

GenericsPharmaceuticalSouth America

Teva to cut 5,000 jobs as it accelerates cost savings plan

Teva to cut 5,000 jobs as it accelerates cost savings plan

10-10-2013

Israel-based Teva Pharmaceutical Industries, the world’s largest generic drugmaker, says it is taking…

FinancialGenericsManagement

Acorda Therapeutics appoints former BG Medicine vice president as chief financial officer

Acorda Therapeutics appoints former BG Medicine vice president as chief financial officer

09-10-2013

Acorda Therapeutics has announced that Michael Rogers has joined the company as chief financial officer.

Acorda TherapeuticsBiotechnologyBoardroomNorth America

Actavis confirms generic Suboxone sublingual film patent challenge

Actavis confirms generic Suboxone sublingual film patent challenge

09-10-2013

Actavis has filed an Abbreviated New Drug Application with the US Food and Drug Administration for buprenorphine…

ActavisGenericsNeurologicalNorth AmericaPatentsReckitt BenckiserSuboxone

Epic Pharma gets rights to sell 12 generics

08-10-2013

Elite Pharmaceuticals (OTCBB: ELTP) has signed a manufacturing and license agreement with fellow USA-based,…

Epic PharmaGenericsLicensingNorth AmericaProduction

Ablynx to appoint three new directors and elect a new chairman of its board

Ablynx to appoint three new directors and elect a new chairman of its board

08-10-2013

Ablynx has announced that Peter Fellner, Bo Jesper Hansen and William Jenkins will be proposed for nomination…

AblynxBoardroomEurope

Teva gets favorable Copaxone patent ruling in Netherlands

Teva gets favorable Copaxone patent ruling in Netherlands

04-10-2013

The District Court of the Hague has issued a favorable ruling for Teva Pharmaceutical Industries in a…

EuropeGenericsLegalNeurologicalPatentsPharmaceutical

226 to 250 of 1322 results

Back to top